Effectiveness of glutamine for the treatment of radiodermatitis in cancer patients: a meta-analysis of randomized controlled trials

Hsu-Chieh Chang,Wen-Yen Huang,Po-Huang Chen,Tsai-Wei Huang,Made Satya Nugraha Gautama
DOI: https://doi.org/10.1007/s00520-024-08411-8
IF: 3.1
2024-03-03
Supportive Care in Cancer
Abstract:After receiving radiation therapy, 60%–95% of patients with cancer develop radiodermatitis, which causes pain, wound infection, and poor quality of life. Glutamine is a popular nutritional supplement for patients with cancer. Several studies examined the usefulness of glutamine for reducing radiodermatitis. However, there is still no consolidated evidence for clinical use.
oncology,health care sciences & services,rehabilitation
What problem does this paper attempt to address?